Fundz

Huons Co., Ltd. acquires stake in PanGen to accelerate biopharmaceutical development

PRIVATENov 07, 2024

Acquiring Company

Huons Group

Acquired Company

PanGen Biotech

Seongnam-siDurhamManufacturingBiotechnologyBiopharmaManufacturingBiotechnology

Description

Huons Co., Ltd. has announced the acquisition of a significant stake in PanGen Biotech Inc. The acquisition is aimed at expanding Huons' biopharmaceutical research and development expertise, as well as strengthening its contract development and manufacturing organization (CDMO) business. This strategic move is expected to enhance Huons' global competitiveness and lead to synergies between affiliates.

Other recent acquisitions in Biopharma and Manufacturing

Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.

Who to call at Huons Group, and when

When Huons Group changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day Huons Group raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Huons Group, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Huons Group. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Huons Group

Location

Seongnam-si, Gyeonggi, South Korea

About

Huons Group is a South Korean conglomerate focusing on the pharmaceutical and biopharmaceutical industries. The company aims to enhance its growth strategy through mergers and acquisitions. It is dedicated to developing innovative healthcare solutions. Huons Group strives to unify its business capabilities for greater efficiency.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Huons Group makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Minyoung
Likely contact at this company
••••••••@••••••••

See Minyoung's verified email →

Mina
Likely contact at this company
••••••••@••••••••

See Mina's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Huons Group's next move

Learn about Strategic plan

Frequently asked

Who acquired PanGen Biotech?

PanGen Biotech was acquired by Huons Group, based in Seongnam-si. The deal was reported on November 7, 2024. Huons Group is a South Korean conglomerate focusing on the pharmaceutical and biopharmaceutical industries. The company aims to enhance its growth strategy through mergers and acquisitions. Huons Group is privately held and operates in Manufacturing.

When did Huons Group acquire PanGen Biotech?

Huons Group's acquisition of PanGen Biotech was reported on November 7, 2024. Huons Co., Ltd. has announced the acquisition of a significant stake in PanGen Biotech Inc. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does PanGen Biotech do?

PanGen Biotech Inc. is a company equipped with Good Manufacturing Practice (GMP) facilities for biopharmaceutical production. It is privately held, operating in Manufacturing, and is based in Durham.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.